NCT06070818

Brief Summary

The goal of this pilot randomised clinical trial is to compare a 12-week Healthy Body \& Mind Program to usual care in older adults living with cognitive decline and osteoarthritis. The main questions it aims to answer are:

  • Does the Healthy Body \& Mind Program improve health-related quality of life in older adults living with cognitive decline and osteoarthritis (pre/post and intervention/control)?
  • Does the Healthy Body \& Mind Program improve other health outcomes (cognition, pain, anxiety/depression, physical function) in older adults living with cognitive decline and osteoarthritis (pre/post and intervention/control)? Participants will complete a co-designed and multidisciplinary 12-week program that includes physical activity and lifestyle education (nutrition, social activity and managing anxiety/depression). Researchers will compare outcomes between the intervention group and a wait-list control to see if there are difference in outcome measures (quality of life, cognition, pain, anxiety/depression, physical function).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 18, 2023

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 25, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 6, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2024

Completed
Last Updated

October 6, 2023

Status Verified

September 1, 2023

Enrollment Period

9 months

First QC Date

September 25, 2023

Last Update Submit

September 30, 2023

Conditions

Keywords

dementialifestylemultidisciplinaryphysical activitynutritiondepressionanxietypainosteoarthritiscognitive decline

Outcome Measures

Primary Outcomes (1)

  • Health-related quality of life questionnaire

    EuroQoL health-related quality of life (EQ-5D; https://euroqol.org/); Score range 0-1; 1 indicating full health, 0 indicating bad health.

    12 weeks

Secondary Outcomes (1)

  • Cognition questionnaire

    12 weeks

Other Outcomes (7)

  • Chronic pain questionnaire

    12 weeks

  • Depression, anxiety & stress questionnaire

    12 weeks

  • Physical function: 6-minute walk test

    12 weeks

  • +4 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Healthy Body \& Mind Program: In summary, the program includes two visits to the University of New South Wales (UNSW) Medicine \& Health Lifestyle Clinic at the beginning and end of the program for Initial and Final Assessments, and two weekly sessions for 12 weeks (24 sessions in total) to the UNSW Medicine \& Health Lifestyle Clinic to complete the Healthy Body \& Mind Program. Participants will also be invited to take part in a focus group either at the clinic or online (via Teams/ zoom) at the end of the program.

Other: Healthy Body & Mind Program

Wait-list control

NO INTERVENTION

Usual care. Participants will not be recruited if they are taking part in another research intervention or receiving treatment other than usual care.

Interventions

12-week physical activity and lifestyle education program

Intervention

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 55 or above.
  • Montreal Cognitive Assessment score 18-25 indicating mild cognitive decline or mild dementia.
  • Diagnosed with osteoarthritis.
  • Able to safely undertake study assessments and complete exercise without assistance.

You may not qualify if:

  • Montreal Cognitive Assessment score below 18.
  • Display an abnormal cardiovascular response to exercise (as seen during the baseline exercise test) and your doctor does not provide medical clearance to exercise.
  • Are unable to speak English and do not have a translator.
  • Have orthopedic or neuromuscular limitations that prevent you from performing the exercise.
  • Are deemed unsuitable for group exercise sessions following initial assessment by an Accredited Exercise Physiologist within the UNSW Lifestyle Clinic.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNSW Medicine & Health Lifestyle Clinic

Sydney, New South Wales, 2052, Australia

RECRUITING

Related Publications (1)

  • Burley CV, Yeates W, McLeod KA, Jones MD, Borges N, Brodaty H, Parmenter BJ. Healthy Body and Mind Program to Improve Health Outcomes and Reduce Dementia Risk in People With Osteoarthritis: Protocol for a Feasibility and Acceptability Pilot Randomized Controlled Trial. JMIR Res Protoc. 2025 Nov 6;14:e75816. doi: 10.2196/75816.

MeSH Terms

Conditions

Cognitive DysfunctionOsteoarthritisDementiaMotor ActivityDepressionAnxiety DisordersPain

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental DisordersArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesBehaviorBehavioral SymptomsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Claire Burley, PhD

CONTACT

Belinda Parmenter, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The researcher collecting the outcome measures will not know whether the person is in the intervention or control group.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: A randomised trial with a wait-list control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator Dr Claire Burley

Study Record Dates

First Submitted

September 25, 2023

First Posted

October 6, 2023

Study Start

September 18, 2023

Primary Completion

June 26, 2024

Study Completion

July 28, 2024

Last Updated

October 6, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations